Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

LLY

Eli Lilly (LLY)

Eli Lilly and Co
일자:
정렬 기준:
 검색 관련기사 보기:NYSE:LLY
일자시간출처헤드라인심볼기업
2024/05/1005:34Edgar (US Regulatory)Form 8-K - Current reportNYSE:LLYEli Lilly and Co
2024/05/0700:32PR Newswire (US)Lilly Declares Second-Quarter 2024 DividendNYSE:LLYEli Lilly and Co
2024/04/3022:07IH Market NewsFutures Pointing To Roughly Flat Open On Wall StreetNYSE:LLYEli Lilly and Co
2024/04/3020:59IH Market NewsU.S. Index Futures Point to Mild Decline Ahead of Key Earnings and Fed Rate DecisionNYSE:LLYEli Lilly and Co
2024/04/3020:55IH Market NewsHSBC’s High Profit & CEO Resignation, Santander’s 11% Profit Surge, and More in EarningsNYSE:LLYEli Lilly and Co
2024/04/3019:45PR Newswire (US)Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline MomentumNYSE:LLYEli Lilly and Co
2024/04/1719:15PR Newswire (US)Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesityNYSE:LLYEli Lilly and Co
2024/04/1623:00PR Newswire (US)Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results AnnouncementNYSE:LLYEli Lilly and Co
2024/04/0320:12IH Market NewsCal-Maine Surges on Strong Quarterly Performance, Taiwan Earthquake Disrupts Tech Supply Chain, and MoreNYSE:LLYEli Lilly and Co
2024/03/1205:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/03/1205:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
2024/03/1105:00PR Newswire (US)More than two-thirds of people with atopic dermatitis and skin of color experienced skin improvement in a first-of-its-kind lebrikizumab studyNYSE:LLYEli Lilly and Co
2024/03/0820:45PR Newswire (US)U.S. Food and Drug Administration to Convene Advisory Committee Meeting to Discuss the TRAILBLAZER-ALZ 2 Study of DonanemabNYSE:LLYEli Lilly and Co
2024/03/0722:00PR Newswire (US)Lilly's Newest Phase of Get Better Campaign Challenges Misperceptions About Obesity CareNYSE:LLYEli Lilly and Co
2024/03/0607:00PR Newswire (US)Lilly Announces Details of Presentations at 2024 American Association for Cancer Research (AACR) Annual MeetingNYSE:LLYEli Lilly and Co
2024/02/2206:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/02/2206:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/02/2206:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/02/2206:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/02/2206:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/02/2106:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/02/2100:00PR Newswire (US)Lilly to Participate in Cowen's 44th Annual Health Care ConferenceNYSE:LLYEli Lilly and Co
2024/02/1706:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/02/1605:05Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
2024/02/1506:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/02/1506:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/02/1506:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/02/1506:39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/02/1506:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
2024/02/1506:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
 검색 관련기사 보기:NYSE:LLY

최근 히스토리

Delayed Upgrade Clock